SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Maravai LifeSciences Q3 Revenue Reaches $45.9 Million

Q3 adjusted EBITDA was $5.8 million, versus the IBES estimate of $512.9 thousand.

MRVI

Related stories